Assessment of safety and tolerability of remogliflozin etabonate (GSK189075) when administered with total daily dose of 2000 mg of metformin

• Auteurs principaux: Robert Dobbins (Auteur), Elizabeth K. Hussey (Auteur), Robin O'Connor-Semmes (Auteur), Susan Andrews (Auteur), Wenli Tao (Auteur), William O. Wilkison (Auteur), Bentley Cheatham (Auteur), Katare Sagar (Auteur), Barkate Hanmant (Auteur)
• Format: Livre
• Publié: BMC, 2021-06-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Abstract Background Patients with type 2 diabetes mellitus (T2DM) are characterized by an elevated glycemic index and are at a higher risk for complications such as cardiovascular disease, nephropathy, retinopathy and peripheral neuropathy. Normalization of glycemic index can be achieved by dosing c...